• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Validating measures of posttraumatic stress, depression, and anxiety screening among conflict‐affected internally displaced persons in Nigeria

Abstract

Nigeria faces multiple overlapping violent conflicts; however, there are few validated mental health screening instruments for these conflict-affected populations. This study validated the PTSD Checklist for DSM-5 (PCL-5), Patient Health Questionnaire–9 (PHQ-9), and Generalized Anxiety Disorder–7 (GAD-7) among 205 conflict-affected people in two internally displaced persons camps in Abuja, Nigeria. Measures were translated into Hausa and Pidgin English and culturally adapted; psychiatrists also administered structured clinical diagnostic interviews. All instruments showed excellent reliability, McDonald’s ωs = .866–. 915, Cronbach’s αs = .864–.915. Confirmatory factor analysis favored a six-factor anhedonia model for the PCL-5 per incremental fit indices, whereas the Bayesian information criterion favored more parsimonious four-factor models. Neither the single-factor nor two-factor PHQ-9 models provided adequate fit, and the GAD-7 fit a unidimensional structure poorly. The PCL-5 showed fair criterion validity, AUC = .706, and performed best at a threshold of 38 points or higher (sensitivity: 56.3%, specificity: 76.5%), outperforming the international standard of 33. The PHQ-9 demonstrated poor criterion validity, AUC = .697. At a 10-point score threshold, sensitivity (69.7%), specificity (68.8%), and negative predictive value (82.6%) supported limited use as a first-stage screener with clinical case confirmation. The GAD-7 demonstrated even lower criterion validity, AUC = .576. Within this population, estimated PTSD (50.2%), depression (32.4%), and anxiety (44.9%) prevalences were high, with comorbid presentations in 40.5% of participants. Population-specific score thresholds improved PCL-5 diagnostic accuracy, and the PCL-5 and PHQ-9 can support screening in this population; the GAD-7 requires further evaluation or supplementation.

Read the full article ›

Posted in: Journal Article Abstracts on 11/04/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice